Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-19 | Y-mAbs Therapeutics, Inc. | Gad Thomas
(CHIEF BUSINESS OFFICER) |
M | Common Stock | A | 22831 | $4.38 - $4.38 | $99,999 |
| 2024-09-13 | Y-mAbs Therapeutics, Inc. | Gad Thomas
(CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 95000 | $12.97 - $13.47 | $1,264,650 |
| 2024-08-26 | Y-mAbs Therapeutics, Inc. | Wilms Joris
(SVP & CHIEF OPERATING OFFICER) |
S | Common Stock | D | 5000 | $14.69 - $14.69 | $73,450 |
| 2024-07-12 | Y-mAbs Therapeutics, Inc. | PFREUNDSCHUH PETE...
(CFO and Treasurer) |
A | Common Stock | A | 46000 | $0.00 - $0.00 | $0 |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. | TAGLIAFERRI MARY
(Director) |
A | Common Stock | A | 3495 | $0.00 - $0.00 | $0 |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. | Hamill Laura
(Director) |
A | Common Stock | A | 3495 | $0.00 - $0.00 | $0 |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsbor...
(Director) |
A | Common Stock | A | 3495 | $0.00 - $0.00 | $0 |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. | HEALY JAMES
(Director) |
A | Common Stock | A | 3495 | $0.00 - $0.00 | $0 |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. | GILL DAVID N
(Director) |
A | Common Stock | A | 3495 | $0.00 - $0.00 | $0 |
| 2024-06-11 | Y-mAbs Therapeutics, Inc. | TYAGI ASHU
(Director) |
A | Common Stock | A | 3495 | $0.00 - $0.00 | $0 |
| 2024-06-10 | Y-mAbs Therapeutics, Inc. | Ber Gerard
(Director) |
S | Common Stock | D | 722 | $12.00 - $12.00 | $8,664 |
| 2024-06-10 | Y-mAbs Therapeutics, Inc. | Gad Thomas
(CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 70000 | $12.00 - $12.03 | $841,050 |
| 2024-05-30 | Y-mAbs Therapeutics, Inc. | Kruse Bo
(EVP, CFO, SECRY & TREAS.) |
S | Common Stock | D | 60000 | $12.03 - $12.07 | $723,053 |
| 2024-05-30 | Y-mAbs Therapeutics, Inc. | Kruse Bo
(EVP, CFO, SECRY & TREAS.) |
M | Common Stock | A | 60000 | $2.00 - $2.00 | $120,000 |
| 2024-05-21 | Y-mAbs Therapeutics, Inc. | Gad Thomas
(CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 32351 | $12.00 - $13.00 | $395,563 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |